SEC
SlamSEC
SearchBrowseEarnings

MCKESSON CORP

NYSE:MCK
Wholesale-Drugs, Proprietaries & Druggists' Sundries·IRVING, TX
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Summary Financials

McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees.

Revenue
$276.7B
+4.8% YoY
FY 2025
Adj. EBITDA
$4.7B
1.7% margin
FY 2025
Net Income
$3.6B
1.3% margin
FY 2025
EPS (Diluted)
$25.03
FY 2025
Stock Price
$919.26
-1.3%
2026-03-06
52W Range
$633.52 – $999.00
P/E Ratio
36.7x
Market Cap
$112.6B
Cash
$4.7B
FY 2025
Total Debt
$3.8B
FY 2011
Net Cash
$908.0M
FY 2011
Enterprise Value
$111.7B
Debt / EBITDA
-0.2x
FY 2025
EV / EBITDA
24.0x
Employees
—